Financial Ratios Maxscend Microelectronics Company Limited
Stocks
300782
CNE100003QK4
Semiconductors
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.71 CNY | +1.09% |
|
+4.09% | +19.92% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 23.76 | 7.33 | 6.67 | 1.8 | -1.53 | |||||
Return on Total Capital | 26.64 | 8.06 | 7.35 | 2 | -1.74 | |||||
Return On Equity % | 41.5 | 13.22 | 12.11 | 4.03 | -2.92 | |||||
Return on Common Equity | 41.44 | 13.1 | 12.14 | 4.02 | -2.92 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 56.35 | 44.5 | 44.26 | 35.8 | 19.38 | |||||
SG&A Margin | 2.1 | 3.78 | 4.59 | 5.29 | 5.81 | |||||
EBITDA Margin % | 48.32 | 31.12 | 29.58 | 20.52 | 8.94 | |||||
EBITA Margin % | 47.37 | 28.66 | 25.04 | 8.16 | -9.67 | |||||
EBIT Margin % | 47.33 | 28.63 | 24.93 | 8.09 | -9.75 | |||||
Income From Continuing Operations Margin % | 46.07 | 29.32 | 25.57 | 8.97 | -7.86 | |||||
Net Income Margin % | 46.07 | 29.07 | 25.63 | 8.96 | -7.86 | |||||
Net Avail. For Common Margin % | 46.07 | 29.07 | 25.63 | 8.96 | -7.86 | |||||
Normalized Net Income Margin | 29.69 | 18.21 | 16.4 | 4.75 | -6.97 | |||||
Levered Free Cash Flow Margin | -49.92 | -26.27 | -22.17 | -48.84 | -20.15 | |||||
Unlevered Free Cash Flow Margin | -49.91 | -26.26 | -22.14 | -48.32 | -18.88 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.8 | 0.41 | 0.43 | 0.36 | 0.25 | |||||
Fixed Assets Turnover | 8.2 | 1.32 | 0.86 | 0.64 | 0.45 | |||||
Receivables Turnover (Average Receivables) | 10.18 | 7.56 | 9.53 | 8.17 | 6.29 | |||||
Inventory Turnover (Average Inventory) | 1.92 | 1.28 | 1.52 | 1.44 | 1.03 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 6.62 | 4.98 | 3.71 | 1.69 | 2.01 | |||||
Quick Ratio | 4.31 | 2.42 | 1.75 | 0.67 | 0.75 | |||||
Operating Cash Flow to Current Liabilities | 1.53 | 1.31 | 2.15 | 0.03 | 0.03 | |||||
Days Sales Outstanding (Average Receivables) | 35.85 | 48.31 | 38.32 | 44.81 | 58.01 | |||||
Days Outstanding Inventory (Average Inventory) | 190.2 | 285.74 | 240.21 | 254.99 | 354.97 | |||||
Average Days Payable Outstanding | 38.16 | 68.05 | 91.59 | 70.91 | 102.77 | |||||
Cash Conversion Cycle (Average Days) | 187.88 | 266.01 | 186.93 | 228.89 | 310.21 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.03 | 0.17 | 0.7 | 25.43 | 35.27 | |||||
Total Debt / Total Capital | 0.03 | 0.17 | 0.69 | 20.27 | 26.07 | |||||
LT Debt/Equity | 0 | 0.12 | 0.61 | 6.75 | 20.12 | |||||
Long-Term Debt / Total Capital | 0 | 0.12 | 0.6 | 5.38 | 14.88 | |||||
Total Liabilities / Total Assets | 9.63 | 8.61 | 10.54 | 28.33 | 36.17 | |||||
EBIT / Interest Expense | 13.26K | 1.9K | 466.95 | 9.77 | -4.79 | |||||
EBITDA / Interest Expense | 13.55K | 2.07K | 557.87 | 25.13 | 4.56 | |||||
(EBITDA - Capex) / Interest Expense | -3.72K | -1.01K | -349.87 | -25.19 | -6.07 | |||||
Total Debt / EBITDA | 0 | 0.01 | 0.05 | 2.78 | 10.07 | |||||
Net Debt / EBITDA | -1.19 | -1.1 | -0.72 | 1.27 | 5.3 | |||||
Total Debt / (EBITDA - Capex) | -0 | -0.03 | -0.08 | -2.77 | -7.57 | |||||
Net Debt / (EBITDA - Capex) | 4.31 | 2.24 | 1.15 | -1.26 | -3.99 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 65.95 | -20.63 | 19.05 | 2.48 | -16.96 | |||||
Gross Profit, 1 Yr. Growth % | 82.79 | -37.32 | 18.39 | -17.09 | -55.06 | |||||
EBITDA, 1 Yr. Growth % | 84.58 | -48.93 | 12.81 | -29.32 | -64.23 | |||||
EBITA, 1 Yr. Growth % | 85.22 | -52.01 | 3.65 | -66.82 | -195.6 | |||||
EBIT, 1 Yr. Growth % | 85.26 | -52 | 3.67 | -66.76 | -200.17 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 99.41 | -49.49 | 3.8 | -64.03 | -172.74 | |||||
Net Income, 1 Yr. Growth % | 99 | -49.92 | 4.95 | -64.2 | -172.89 | |||||
Normalized Net Income, 1 Yr. Growth % | 87.57 | -51.33 | 7.23 | -70.29 | -221.78 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 93.71 | -50.03 | 4.77 | -64.19 | -172.86 | |||||
Accounts Receivable, 1 Yr. Growth % | 69.5 | -30.05 | 29.39 | 11.75 | 3.78 | |||||
Inventory, 1 Yr. Growth % | 133.45 | 16.53 | -13.2 | 68.88 | 31.78 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 781.26 | 348.41 | 24.61 | 46.42 | 0.49 | |||||
Total Assets, 1 Yr. Growth % | 173.37 | 12.5 | 15.3 | 29.89 | 8.68 | |||||
Tangible Book Value, 1 Yr. Growth % | 191.29 | 13.11 | 13.11 | 3.78 | -3.44 | |||||
Common Equity, 1 Yr. Growth % | 187.32 | 13.6 | 12.91 | 4.04 | -3.21 | |||||
Cash From Operations, 1 Yr. Growth % | 14.36 | -18.05 | 101.02 | -95.76 | 29.29 | |||||
Capital Expenditures, 1 Yr. Growth % | 1.76K | -40.15 | 24.03 | -11.96 | -56.87 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -535.18 | -58.25 | 0.48 | 125.79 | -65.77 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -535.16 | -58.26 | 0.36 | 123.74 | -67.59 | |||||
Dividend Per Share, 1 Yr. Growth % | 26.01 | -61.14 | 31.62 | -54.46 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 75.04 | 14.76 | -2.79 | 10.46 | -7.75 | |||||
Gross Profit, 2 Yr. CAGR % | 83.21 | 7.04 | -13.85 | -0.92 | -38.96 | |||||
EBITDA, 2 Yr. CAGR % | 100.49 | -2.88 | -23.98 | -10.44 | -49.43 | |||||
EBITA, 2 Yr. CAGR % | 101.89 | -5.69 | -29.35 | -41.14 | -42.86 | |||||
EBIT, 2 Yr. CAGR % | 101.94 | -5.69 | -29.45 | -41.3 | -42.3 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 107.78 | 0.37 | -27.58 | -38.9 | -48.85 | |||||
Net Income, 2 Yr. CAGR % | 107.22 | -0.17 | -27.49 | -38.7 | -48.92 | |||||
Normalized Net Income, 2 Yr. CAGR % | 99.16 | -4.46 | -27.76 | -43.56 | -39.85 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 91.25 | -1.62 | -27.64 | -38.75 | -48.92 | |||||
Accounts Receivable, 2 Yr. CAGR % | 23.01 | 8.89 | -4.86 | 20.24 | 7.69 | |||||
Inventory, 2 Yr. CAGR % | 100.77 | 64.93 | 0.57 | 21.07 | 49.18 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 275.19 | 528.62 | 136.38 | 35.07 | 21.3 | |||||
Total Assets, 2 Yr. CAGR % | 109.59 | 75.37 | 13.89 | 22.38 | 18.81 | |||||
Tangible Book Value, 2 Yr. CAGR % | 111.11 | 81.51 | 13.11 | 8.34 | 0.11 | |||||
Common Equity, 2 Yr. CAGR % | 111.83 | 80.67 | 13.26 | 8.39 | 0.35 | |||||
Cash From Operations, 2 Yr. CAGR % | 354.66 | -3.19 | 28.35 | -70.81 | -76.59 | |||||
Capital Expenditures, 2 Yr. CAGR % | 444.96 | 233.92 | -13.84 | 4.5 | -38.38 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 241.2 | 34.82 | -35.23 | 50.61 | -12.05 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 241.19 | 34.8 | -35.28 | 49.83 | -14.81 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.49 | -30.03 | -28.48 | -22.54 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 102.24 | 34.47 | 16.18 | -1.07 | 0.44 | |||||
Gross Profit, 3 Yr. CAGR % | 110.37 | 28.14 | 10.7 | -14.95 | -23.87 | |||||
EBITDA, 3 Yr. CAGR % | 136.92 | 27.12 | 2.2 | -25.65 | -33.79 | |||||
EBITA, 3 Yr. CAGR % | 138.76 | 25.09 | -2.56 | -44.95 | -30.15 | |||||
EBIT, 3 Yr. CAGR % | 138.71 | 25.09 | -2.67 | -45.11 | -29.85 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 136.99 | 29.68 | 1.5 | -42.65 | -35.24 | |||||
Net Income, 3 Yr. CAGR % | 136.04 | 29.08 | 1.52 | -42.69 | -35.06 | |||||
Normalized Net Income, 3 Yr. CAGR % | 129.1 | 24.51 | -0.71 | -46.28 | -27.07 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 112.54 | 22.26 | 0.47 | -42.76 | -35.1 | |||||
Accounts Receivable, 3 Yr. CAGR % | 132.68 | 1.91 | 15.33 | 0.38 | 14.48 | |||||
Inventory, 3 Yr. CAGR % | 122.15 | 67.47 | 33.16 | 19.54 | 24.54 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 222.65 | 298.16 | 266.53 | 101.5 | 22.39 | |||||
Total Assets, 3 Yr. CAGR % | 149.87 | 70.33 | 52.49 | 18.99 | 17.63 | |||||
Tangible Book Value, 3 Yr. CAGR % | 152.52 | 71.46 | 55.04 | 9.91 | 4.26 | |||||
Common Equity, 3 Yr. CAGR % | 152.4 | 72.1 | 54.47 | 10.1 | 4.38 | |||||
Cash From Operations, 3 Yr. CAGR % | 104.58 | 156.83 | 23.51 | -58.82 | -52.06 | |||||
Capital Expenditures, 3 Yr. CAGR % | 363.18 | 160.97 | 140.03 | -13.22 | -22.2 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 260.59 | 69.42 | 22.24 | -1.8 | -8.06 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 260.59 | 69.4 | 22.18 | -2.14 | -10.03 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | -23.9 | -13.62 | -38.45 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 64.45 | 44.11 | 50.87 | 24.3 | 5.94 | |||||
Gross Profit, 5 Yr. CAGR % | 61.85 | 38.35 | 47.19 | 15.61 | -12.75 | |||||
EBITDA, 5 Yr. CAGR % | 89.11 | 39.93 | 50.38 | 10.57 | -22.78 | |||||
EBITA, 5 Yr. CAGR % | 88.86 | 38.01 | 46.72 | -7.41 | -21.18 | |||||
EBIT, 5 Yr. CAGR % | 88.84 | 37.98 | 46.59 | -7.57 | -21.04 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 90.92 | 44.79 | 47.49 | -4.02 | -22.83 | |||||
Net Income, 5 Yr. CAGR % | 90.92 | 44.47 | 47.21 | -4.17 | -22.87 | |||||
Normalized Net Income, 5 Yr. CAGR % | 87.21 | 40.78 | 44.39 | -9.27 | -18.75 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 77.89 | 35.6 | 38.12 | -7.26 | -23.35 | |||||
Accounts Receivable, 5 Yr. CAGR % | 78.29 | 50.34 | 62.7 | 8.88 | 12.21 | |||||
Inventory, 5 Yr. CAGR % | 90.71 | 80.5 | 61.8 | 47.09 | 39.35 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 191.76 | 219.44 | 184.89 | 158.38 | 135.51 | |||||
Total Assets, 5 Yr. CAGR % | 109.75 | 92.13 | 82.48 | 49.23 | 38 | |||||
Tangible Book Value, 5 Yr. CAGR % | 120.97 | 94.39 | 83.14 | 42.7 | 30.15 | |||||
Common Equity, 5 Yr. CAGR % | 121.28 | 94.67 | 83.18 | 43.04 | 29.99 | |||||
Cash From Operations, 5 Yr. CAGR % | 64.83 | 48.94 | 69.78 | 7.62 | -36.5 | |||||
Capital Expenditures, 5 Yr. CAGR % | 263.03 | 155.4 | 136.36 | 80.97 | 39.33 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 130.96 | 70.81 | 81.47 | 61.63 | 7.15 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 130.33 | 70.77 | 81.41 | 61.28 | 5.76 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | -23.36 | - |
Select your edition
All financial news and data tailored to specific country editions
















